PATENT CLAIM ANALYSIS

Application Number: 16138509
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["544", "090000"]

Abstract:
This invention relates to deuterated analogs of etifoxine of Formula 1, solvates, prodrugs, and pharmaceutically acceptable salts thereof, as well as to methods for their preparation and use, and to pharmaceutical compositions. Briefly, this invention is generally directed to deuterated analogs of etifoxine as well as to methods for their preparation and use, and to pharmaceutical compositions containing the same.

Claim (Index 6):
A method of modulating the GABA A  receptor complex in a subject in need thereof comprising administering to said subject an effective amount of the compound of  claim 1 .

Metadata:
- Claim Count in Document: 35.0
- Percentile: 97.0
- Lexical Diversity: 1.91667
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15557748', '15961002', '15117544', '15610153', '16025512']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.719312575152197
- 35 USC 102 Novelty (BERT): 0.536083237541153
- Combined Prediction Score: 0.7009896413910927
- Mean Citation Score: 255.67116600000003
- Max Citation Score: 367.88748
- Similarity Product: 364.6406083467364

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test